India, Dec. 29 -- image credit- freepik

Corona Remedies has announced the successful commencement of capacity expansion for commercial production of tablets and capsules at its Bhayla manufacturing facility, effective from December 22, 2025.

This strategic expansion aims to meet the growing market demand and enhance the company's in-house production capabilities. With this addition, the installed capacity of the facility will increase by 400 million, raising the available capacity by 240 million.

This milestone reinforces the company's commitment to optimising production and streamlining its supply chain. The expansion is fully funded through internal accruals and is expected to improve operational efficiency and ensure a more agile su...